Assignee
MORPHOTEK INC
US·41 granted patents·11 pending applications·240 citations·filing 2000–2017
Top patents by PatentIndex Score
52 records- 0197US7592426B2Anti-mesothelin antibodiesMORPHOTEK INC·Filed 2006·Granted Sep 22, 2009·38 cites·14 claims
- 0295US9115197B2Anti-mesothelin antibodiesMORPHOTEK INC·Filed 2014·Granted Aug 25, 2015·15 cites·16 claims
- 0395US6808894B1Methods for generating genetically altered antibody producing cell lines with improved antibody characteristicsMORPHOTEK INC·Filed 2000·Granted Oct 26, 2004·43 cites·21 claims
- 0494US7615372B2Antibodies with immune effector activity and that internalize in endosialin-positive cellsMORPHOTEK INC·Filed 2006·Granted Nov 10, 2009·12 cites·12 claims
- 0593US7741450B2Antibodies to GM-CSFMORPHOTEK INC·Filed 2007·Granted Jun 22, 2010·21 cites·6 claims
- 0692US8524237B2Antibodies with immune effector activity and that internalize in endosialin-positive cellsMORPHOTEK INC·Filed 2012·Granted Sep 3, 2013·6 cites·14 claims
- 0789US7807382B2Methods for inhibiting the binding of endosialin to ligandsMORPHOTEK INC·Filed 2008·Granted Oct 5, 2010·11 cites·8 claims
- 0887US6576468B1Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cellsMORPHOTEK INC·Filed 2000·Granted Jun 10, 2003·14 cites·18 claims
- 0986US8895704B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2013·Granted Nov 25, 2014·6 cites·6 claims
- 1085US9650440B2Monoclonal antibodies that specifically block biological activity of a tumor antigenMORPHOTEK INC·Filed 2013·Granted May 16, 2017·5 cites·16 claims
- 1185US6737268B1Method for generating genetically altered antigensMORPHOTEK INC·Filed 2000·Granted May 18, 2004·10 cites·10 claims
- 1284US9359428B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2014·Granted Jun 7, 2016·4 cites·4 claims
- 1383US7235643B2Antibodies and methods for generating genetically altered antibodies with high affinityMORPHOTEK INC·Filed 2002·Granted Jun 26, 2007·7 cites·5 claims
- 1482US9868780B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2016·Granted Jan 16, 2018·2 cites·4 claims
- 1582US7671179B2Antibodies and methods for generating genetically altered antibodies with high affinityMORPHOTEK INC·Filed 2007·Granted Mar 2, 2010·3 cites·5 claims
- 1682US7604994B2Genetically altered antibody-producing cell lines with improved antibody characteristicsMORPHOTEK INC·Filed 2004·Granted Oct 20, 2009·5 cites·29 claims
- 1781US6900370B2Method for generating hypermutable plantsMORPHOTEK INC·Filed 2000·Granted May 31, 2005·10 cites·12 claims
- 1880US9234015B2Chlorotoxin polypeptides and conjugates and uses thereofMORPHOTEK INC·Filed 2014·Granted Jan 12, 2016·3 cites·16 claims
- 1979US7223598B2Methods for isolating novel antimicrobial agents from hypermutable mammalian cellsMORPHOTEK INC·Filed 2005·Granted May 29, 2007·2 cites·7 claims
- 2078US7754450B2Methods of generating high-production of antibodies from hybridomas created by in vitro immunizationMORPHOTEK INC·Filed 2003·Granted Jul 13, 2010·5 cites·45 claims
- 2177US8658173B2Anti-mesothelin antibodiesMORPHOTEK INC·Filed 2013·Granted Feb 25, 2014·1 cites·11 claims
- 2277US6982169B2Chemical inhibitors of mismatch repairMORPHOTEK INC·Filed 2001·Granted Jan 3, 2006·4 cites·29 claims
- 2376US9522195B2Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsMORPHOTEK INC·Filed 2015·Granted Dec 20, 2016·1 cites·12 claims
- 2475US9139656B2TEM-1 diagnostic antibodiesMORPHOTEK INC·Filed 2013·Granted Sep 22, 2015·2 cites·12 claims
- 2573US9505842B2Methods for inhibiting the binding of endosialin to ligandsMORPHOTEK INC·Filed 2014·Granted Nov 29, 2016·1 cites·5 claims
- 2672US9637526B2Chlorotoxin polypeptides and conjugates and uses thereofMORPHOTEK INC·Filed 2015·Granted May 2, 2017·1 cites·72 claims
- 2772US7638334B2Method for generating engineered cells by homologously recombining segments having increased degeneracyMORPHOTEK INC·Filed 2003·Granted Dec 29, 2009·3 cites·46 claims
- 2869US9603952B2Treatment of metastatic tumorsMORPHOTEK INC·Filed 2015·Granted Mar 28, 2017·1 cites·33 claims
- 2969US2006239910A1Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsMORPHOTEK INC·Filed 2006·Application pending·0 cites
- 3068US2015010473A1Diagnosis and treatment of tumorsMORPHOTEK INC·Filed 2014·Application pending·0 cites
- 3164US9422367B2Antigenic GM-CSF peptides and antibodies to GM-CSFMORPHOTEK INC·Filed 2013·Granted Aug 23, 2016·0 cites·20 claims
- 3264US8956832B2Cells expressing anti-GD2 antibodies and methods related theretoMORPHOTEK INC·Filed 2013·Granted Feb 17, 2015·0 cites·4 claims
- 3364US7807416B2Antibodies and methods for generating genetically altered antibodies with enhanced effector functionMORPHOTEK INC·Filed 2008·Granted Oct 5, 2010·0 cites·7 claims
- 3463US10253106B2Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cellsMORPHOTEK INC·Filed 2016·Granted Apr 9, 2019·0 cites·4 claims
- 3563US7332584B2Antibodies that specifically bind PMS2MORPHOTEK INC·Filed 2004·Granted Feb 19, 2008·3 cites·8 claims
- 3663US2010021996A1Genetically Altered Anti-body Producing Cell Lines With Improved Antibody CharacteristicsMORPHOTEK INC·Filed 2009·Application pending·0 cites
- 3762US7939324B2Methods for isolating novel antimicrobial agents from hypermutable mammalian cellsMORPHOTEK INC·Filed 2007·Granted May 10, 2011·0 cites·5 claims
- 3861US10053509B2Methods for inhibiting the binding of endosialin to ligandsMORPHOTEK INC·Filed 2016·Granted Aug 21, 2018·0 cites·2 claims
- 3961US10023632B2Antigenic GM-CSF peptides and antibodies to GM-CSFMORPHOTEK INC·Filed 2016·Granted Jul 17, 2018·0 cites·8 claims
- 4060US10183975B2Chlorotoxin polypeptides and conjugates and uses thereofMORPHOTEK INC·Filed 2017·Granted Jan 22, 2019·0 cites·29 claims
- 4160US2004158886A1Method for generating genetically altered antigensMORPHOTEK INC·Filed 2004·Application pending·0 cites
- 4259US9915660B2Methods for determining prognosis of colorectal cancerMORPHOTEK INC·Filed 2014·Granted Mar 13, 2018·0 cites·14 claims
- 4357US9512223B2Methods for treatment of gastric cancerMORPHOTEK INC·Filed 2013·Granted Dec 6, 2016·1 cites·6 claims
- 4457US2005232919A1Monoclonal antibodies that specifically block biological activity of a tumor antigenMORPHOTEK INC·Filed 2005·Application pending·0 cites
- 4556US2008124744A1Antibodies That Specifically Bind PMS2MORPHOTEK INC·Filed 2007·Application pending·0 cites
- 4656US2004115695A1Methods for generating enhanced antibody producing cell lines with improved growth characteristicsMORPHOTEK INC·Filed 2003·Application pending·0 cites
- 4752US9771429B2TEM-1 diagnostic antibodiesMORPHOTEK INC·Filed 2015·Granted Sep 26, 2017·0 cites·13 claims
- 4849US2016311921A1Methods for treatment of ovarian cancerMORPHOTEK INC·Filed 2014·Application pending·0 cites
- 4945US2008131427A1Whole Genome Evolution Technology Applied To Improve Protein And Antibody Yields By CellsMORPHOTEK INC·Filed 2007·Application pending·0 cites
- 5037US2010260769A1Endosialin binding moleculesMORPHOTEK INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →